Equity Capital Markets

Crinetics Pharmaceuticals, Inc.

10/24
|
$500.0 Million
crinetics
Piper Sandler served as bookrunner for Crinetics Pharmaceuticals, Inc. on its CMFO
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$100.0 Million
Abacus Life
Abacus Life, Inc
Follow-On Offering
Active Bookrunner
$230.0 Million
Farmers
Merchants Bancorp
7.625% Fixed Rates Series E Non-Cumulative Perpetual Preferred Stock
Active Bookrunner
One Stream
OneStream Software
Follow-On Offering
Passive Bookrunner
$80.6 Million
Mid Penn Bancorp, Inc.
Mid Penn Bancorp, Inc.
Common Stock Offering
Active Bookrunner
$175.0 Million
Procept Biorobotics Corp.
Procept Biorobotics Corp.
Follow-On Offering
Active Bookrunner
$60.1 Million
enGene, Inc.
enGene, Inc.
PIPE
Joint Placement Agent
Marex Group plc
Marex Group plc
Follow-On Offering
Passive Bookrunner
$75.0 Million
capricor
Capricor Therapeutics, Inc.
Follow-on offering
Left Bookrunner
$75.0 Million
Camp4
CAMP4
Initial Public Offering
Active Bookrunner
$297.5 Million
Upstreambio
Upstream Bio, Inc.
Initial Public Offering
Active Bookrunner
$300.0 Million
Scholar rock
Scholar Rock Holding Corporation
Follow-On Offering
Active Bookrunner
$500.0 Million
crinetics
Crinetics Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$40.7 Million
chain bridge
Chain Bridge Bancorp
Initial Public Offering
Active Bookrunner
Prairie Operating
Prairie Operating Co
PIPE
Lead Placement Agent
$165.0 Million
Amerant Bancorp Inc.
Amerant Bancorp Inc.
Common Stock Offering
Active Bookrunner
$488.7 Million
Viper
Viper Energy Partners LP
Confidentially Marketed Follow-On Offering
Co-Manager

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.